Hemostasis and fibrinolysis in arteriosclerosis;Gerinnung und Fibrinolyse bei arteriosklerose

Zeitschrift fur Kardiologie

Volumn 88, Issue 5, 1999, Pages 315-323

  Hoffmeister, H M ^a   Heller, W ^a   Seipel, L ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Atherosclerosis; Coagulation; Fibrinolysis; Hemostasis; Inflammation

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; TISSUE PLASMINOGEN ACTIVATOR;

ARTERIOSCLEROSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; COMPLEX FORMATION; CORONARY ARTERY DISEASE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INFLAMMATION; POPULATION RISK; REVIEW; THROMBOGENESIS; THROMBOSIS;

BLOOD COAGULATION FACTORS; CORONARY ARTERIOSCLEROSIS; CORONARY THROMBOSIS; FIBRINOLYSIS; HUMANS; THROMBOPHILIA;

EID: 0032991908     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050292     Document Type: Review

References (96)

1. Agostoni A, Gardinali M, Frungi D, Cafaro C, Conciato L, Sponzilli C, Salvioni A, Cugno M, Cicardi M, (1994) Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. Circulation 90:2666-2670
2. Angleton P, Chandler WL, Schmer G (1989) Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 79:101-106
3. Ardissino D, Merlini PA, Gambo G, Barberis P, Demichelli G, Testa S, Colombi E, Poli A, Fetiveau R, Montemartini C (1996) Thrombin activity and early outcome in unstable angina pectoris. Circulation 93:1634-1639
4. Becker RC, Tracy RP, Bovill EG, Mann KG, Ault K (1994) Clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. Coronary Artery Disease 5:339-345
5. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ (1995) Atherosclerosis: Basic Mechanisms. Circulation 91:2488-2496
6. Biasucci LM, Liuzzo G, Caligiuri G. Quaranta G, Andreotti F, Sperti G, van de Greef W, Rebuzzi AG, Kluft C, Maseri A (1996) Temporal relation between ischemic episodes and activation of the coagulation system in unstable angina. Circulation 93:2121-2127
7. Capron L (1996) Chlamydia in coronary plaques - hidden culprit or harmless hobo? Nature Med 2:856-857
8. Carvalho de Sousa J, Azevedo J, Soria C. Barros F, Ribeiro C, Parreira F, Caen JP (1988) Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation. Thromb Res 51:165-173
9. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM (1993) C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82:513-520
10. Chandler WL, Alessi MC, Aillaud MF, Henderson P, Vague P, Juhan-Vague I (1997) Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex. Circulation 96:761-768
11. Depré C, Wijns W, Robert AM, Renkin JP, Havaux X (1997) Pathology of unstable plaque: correlation with the clinical severity of acute coronary syndromes. J Am Coll Cardiol 30:694-702
12. ECAT angina pectoris study group (1993) ECAT angina pectoris study: baseline associations of haemostatic factor with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Europ Heart J 14:8-17
13. Eisenberg PR, Sherman LA, Scheetman K, Perez J, Sobel BE, Jaffe AS (1985) Fibrino peptide A: a marker of acute coronary thrombosis. Circulation 71:912-918
14. Eisenberg PR, Kenzora JL, Sobel BE, Ludbrook PA, Jaffe AS (1991) Relation between ST segment shifts during ischemia and thrombin activity in patients with unstable angina pectoris. J Am Coll Cardiol 18:898-903
15. Eisenberg PR, Sobel BE, AS (1992) Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activator. J Am Coll Cardiol 19:1065-1069
16. Entman ML, Ballantyne CM (1993) Inflammation in acute coronary syndromes. Circulation 22:800-803
17. Epstein SE, Speir E, Zhou YF, Guetta E, Leon M, Finkel T (1996) The role of infection in restenosis and atherosclerosis focus on cytomegalovirus. Lancet 348:13-17
18. Ernst E, Resch KL (1993) Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 12:956-963
19. Esmon CT. (1995) Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 9:946-955
20. Esmon CT, Fukodome K, Mather T, Bode W, Esmon NL, Regan LM, Stearns-Kurosawa DJ, Kurosawa S (1997) Inflammation: the protein C pathway. Fibrinolysis & Proteolysis 11 (Suppl 1):143-148
21. Ewald GA, Eisenberg PR (1995) Plasmin-mediated activation of contact system in response to pharmacological thrombolysis. Circulation 91:28-36
22. Falk E, Shah PK, Fuster V (1995) Coronary plaque disruption. Circulation 92:657-671
23. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L (1994) Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 23:1562-1569
24. Folsom AR, Wu KK, Rosamond WD, Sharett AR, Chambless LE (1997) Prospective study of hemostatic factors and incidence of coronary heart disease. The ARIC Study. Circulation 96:1102-1108
25. Francis RB, Kawanishi D, Baruch T, Mahrer P, Rahimtoola S, Feinstein DI (1988) Impaired fibrinolysis in coronary artery disease. Am Heart J 115:776-780
26. Fuster V, Stein B, Ambrose JA, Badimon L, Badimon JJ, Chesebro JH (1990) Atherosclerotic plaque rupture and thrombosis. Circulation 82 (suppl II):II-47-II-59
27. Fuster V, Lewis A, Conner Memorial Lecture (1994) Mechanisms leading to myocardial infarction: insights from the studies of vascular biology. Circulation 90:2126-2146
28. Fujii S, Sawa H, Sffitz JE, Lucore CL, Sobel BE (1992) Induction of endothelial cell expression of the plasminogen activator inhibitor type I gene by thrombosis in vivo. Circulation 86:2000-2010
29. Galis Z, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2501
30. Gotoh K, Minamino T, Katoh O, Hamano Y, Fukui S, Hori M, Kusuoka H, Mishima M, Inoue M, Kamada T (1988) The role of intracoronary thrombus in unstable angina: angiographic assessment and thrombolytic therapy during ongoing anginal attacks. Circulation 77:526-534
31. Hamsten A, Walldius G. Szamosi A, Blombäck M, De Faire U, Dahlen G, Landou C, Wiman B (1987) Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet ii:3-9
32. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349:462-466
33. Helber U, Jur M, Waldenmaier S, Heller W, Hoffmeister HM (1996) Coagulation and fibrinolysis in patients with acute coronary syndromes in the follow-up. Fibrinolysis 10 (Suppl. 1):32
34. Helber U, Büttcher E, Beyer ME, Hoffmeister HM (1997) Expression des Adhäsionsmoleküls MAC-1 auf Granulozyten bei Patienten mit instabiler Angina pectoris. Relation zu ΔtPA. In: Heinle H, Schulte H, Siegel G (Hrsg) Adhäsionsmoleküle, Zytokine und Apoptose bei der Gefäßumgestaltung. W. Kohlhammer, Stuttgart, S 78-82
35. Hoffmeister HM, Fuhrer G, Hoffmeister HE, Heller W (1990) Early and delayed effects of ionic and non-ionic contrast media on the contact phase and the complement cascade in vivo. Thromb Haemorrh Disorders 2/1:31-35
36. Hoffmeister HM, Jur M, Wendel HP, Heller W, Seipel L (1995) Alterations of the coagulation, the fibrinolytic and the kallikreinkinin system in the acute and post-acute phase in patients with unstable angina pectoris. Circulation 91:2520-2527
37. Hoffmeister HM, Jur M, Ruf M, Heller W, Seipel L (1995) Inhibitors of the hemostasis and related systems in patients with acute myocardial infarction or unstable angina pectoris. Fibrinolysis 9 (Suppl 1): 104-108
38. Hoffmeister HM, Jur M, Heller W, Seipel L (1997) Lack of impact of angioplasty on the time course of elevated coagulation and fibrinolysis parameters in unstable angina pectoris. Fibrinolysis & Proteolysis 11:221-227
39. Hoffmeister HM, Ruf M, Wendel HP, Heller W, Seipel L (1998) Streptokinase-induced activation of the kallikrein-kinin system and of the contact phase in patients with acute myocardial infarction. Cardiovasc Pharmacol 31:764-772
40. Hoffmeister HM, Jur M, Ruf-Lehmann M, Helber U, Heller W, Seipel L (1998) Endothelial tissue-type plasminogen activator release in coronary heart disease. J Am Coll Cardiol 31:547-551
41. Hoffmeister HM, Szabo S, Kastner C, Helber U, Beyer ME, Kazmaier S, Heller W, Seipel L (1998) Activation of the bradykinin-kallikrein system, of the coagulation and fibrinolysis by direct and non-direct plasminogen activating thrombolytic agents in myocardial infarction (Abstract). Eur Heart J 19 (Suppl):356
42. Hoffmeister HM, Büttcher E, Ehlers R, Kazmaier S, Wendel HP, Helber U, Heller W (1998) Increased leukocyte-platelet adhesion parallels platelet activation in acute coronary syndromes. Circulation 98 (Suppl):I-171
43. Hoffmeister HM, Szabo S, Kastner C, Beyer ME, Helber U, Kazmaier S, Wendel HP, Heller W, Seipel L (1998) Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and alteplase regimen with focus on the kallikrein system and plasmin. Circulation 98:2527-2533
44. Hoffmeister HM, Jur M, Helber U, Fischer M, Heller W, Seipel L (1999) Correlation between coronary morphology and molecular markers of fibrinolysis in unstable angina pectoris. Atherosclerosis (in press)
45. Humphries SE, Thomas A, Montgomery HE, Green F, Winder A, Miller G (1997) Gene-environment interaction in the determination of plasma levels of fibrinogen. Fibrinolysis & Proteolysis 11 (Suppl 1): 3-7
46. Hwang SJ, Ballantyne CM, Sharrett R, Smith LC, Davis CE, Gotto AM, Boerwinkle E (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. Circulation 96: 4219-4225
47. Ikonomidis I, Stefanades C, Economou E, Petsavos C, Andreotti F, Tutuzas P, Nihoyannopoulos P (1998) Low dose aspirin reduces elevated C-reactive protein plasma levels in patients with chronic stable angina by reducing cytokine plasma levels. Circulation 98 (Suppl):I-563
48. Juhan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG (1996) Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 94:2057-2063
49. Jur M, Heller W, Hoffmeister HM, Seipel L (1995) Komplementsystem, Kreatinkinase und Leukozytenaktivierung bet Patienten mit instabiler Angina pectoris Symptomatik. In: Heinle H, Schulte HJ, Kaffarnik H (Hrsg) Arteriosklerose. W. Kohlhammer, Stuttgart, S 351-354
50. Kapiotis S, Jilman B, Quehenberger P, Ruzicka K, Handler S, Speiser W (1997) Morning hypercoagulability and hypofibrinolysis. Circulation 96:19-21
51. Kienast J, Thompson G, Raskino C, Pelzer H, Fechtrup C, Ostermann H, van de Loo J (1993) Prothrombin activation fragment 1+2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis. Thromb and Haemostas 70:550-553
52. Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE (1987) Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. N Engl J Med 317:1361-1365
53. Li H, Cybulsky MI, Gimbrone MA, Libby P (1993) An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arteriosel & Thromb 13:197-204
54. Libby P, Egan D, Skarlator S (1997) Roles of infectious agents in atherosclerosis and restenosis. Circulation 96:4095-4103
55. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A (1994) The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331:417-424
56. Liuzzo G, Biasucci LM, Rebuzzi AG, Gallimore R, Caligiuri G, Lanza GA. Quaranta G, Monaco C, Pepys MB, Maseri A (1996) Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation 94:2373-2380
57. Lucore CL, Sobel BE (1988) Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications. Circulation 77:660-669
58. Marmur JD, Thiruvikraman V, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB (1996) Identification of active tissue factor in human coronary atheroma. Circulation 94: 1226-1232
59. Mazzone A, De Servi S, Ricevuti G, Mazzucchelli I, Fossati G, Pasotti D, Bramucci E, Angoli L, Marsico F, Speechia G, Noratio A (1993) Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 88:358-363
60. Meade TW, Brozovic M, Chakrabarti RR, Haines AP, Imeson JD, Mellows S, Miller J, North WRS, Stirling Y, Thompson SG (1986) Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 2:533-537
61. Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C, Mannucci PM, Rosenberg RD (1994) Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 90:61-68
62. Miller GJ, Esnouf MP, Burgess AI, Cooper JA, Mitchell JP (1997) Risk of coronary heart disease and activation of factor XII in middle-aged men. Arterioscler Thromb Vasc Biol 17:2103-2106
63. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT (1994) Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 90:775-778
64. Moreno PR, Bernardi VH, López-Cuéllar J, Murcia AM, Palacios IF, Gold HK, Mehran R, Sharma SK, Nemerson Y, Fuster V, Fallon JT (1996) Macrophages, smooth muscle cells, and tissue factor in unstable angina. Circulation 94:3090-3097
65. Munkvad S, Gram J, Jespersen J (1990) A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction. Eur Heart J 11:525-528
66. Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L (1997) Thrombin, thrombomodulin and TAF1 in the molecular link between coagulation and fibrinolysis. Thrombosis & Hemostasis 78:386-391
67. Neumann FJ, Marx N, Gawaz M, Brand K, Ott I, Rokitta C, Sticherling C, Meint C, May A, Schömig A (1997) Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 95:2387-2394
68. Neumann FJ, Ott I, Marx N, Luther T, Kenngott S, Gawaz M, Kotzsch M, Schomig A (1997) Effect of human recombinant interleukin-6 and interleukin 8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 17:3399-3405
69. Noda-Heiny H, Daugherty A, Sobel BE (1995) Augmented urokinase receptor expression in atheroma. Arterioscler Thromb Vasc Biol 15:37-43
70. Okada K, Lijnen HR, Moreau H, Vanderschueren S, Collen D (1996) Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activator. Thromb Hemostasis 76:857-859
71. Padró T, Emeis JJ, Steins M, Schmid KW, Kienasi J (1995) Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease. Arterioscler Thromb Vasc Biol 15:893-902
72. Pfohl M, Schreiber I, Liebich H, Smykowski J, Häring HU, Hoffmeister HM (1998) The decrease in serum lipids and lipoproteins after acute myocardial infarction is related to profound upregulation of whole body cholesterol biosynthesis. Atherosclerosis (in press)
73. Rapold HJ, Kuemmerli H, Weiss M, Baur H, Hacberli A (1989) Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator. Circulation 79:980-989
74. Richardson PD, Davies MJ, Born GVR (1989) Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 2:941-944
75. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH (1993) Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 341:1165-1168
76. Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ (1994) Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 90:2236-2240
77. Ridker PM (1997) Endogenous fibrinolytic function and risks of future myocardial infarction and stroke: observation from the Physicians' Health Study. Fibrinolytic & Proteolysis 11 (Suppl 1):55-59
78. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979
79. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J (1998) Plasma concentration of soluble intercellular adhesion molecule-1 and risks of future myocardial infarction in apparently healthy men. Lancet 351:88-92
80. Schaiff WT, Eisenberg PR (1997) Mechanisms for thrombolysis-induced increases in procoagulant and proinflammatory activity. Fibrinolysis & Proteolysis 11 (Suppl 1):115-118
81. Scharfstein J, Abendschein DR, Eisenberg PR, George D, Cannon CP, Becker RC, Sobel B, Cupples LA, Braunwald E (1996) Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. Am J Cardiol 78:503-510
82. Schmaier AH, Silverberg M, Kaplan AP, Colman RW (1987) Contact activation and its abnormalities. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds) Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 2nd Ed. Philadelphia: J. B. Lippincott, pp 18-38
83. Sweetnam PM, Thomas HF, Yarnell JWG, Beswick AD, Baker IA, Elwood PC (1996) Fibrinogen, viscosity and the 10-year-incidence of ischaemic heart disease. Eur Heart J 17:1814-1820
84. Sylen C, Hagerman I, Karlberg KE, Chen J, Wallin R, Eneroth P, Bergström K, Saldeen T (1995) Platelet and leukocyte activation after myocardial infarction. Eur Heart J 16:1800-1806
85. Szabo S, Kastner C, Büttcher E, Kazmaier S, Helber U, Hoffmeister HM (1998) Altersabhängigkeit von Markern der Hämostase und Fibrinolyse In: Heinle H, Schulte H, Siegel G (Hrsg) Arteriosklerose. W. Kohlhammer, Stuttgart (in press)
86. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW (1995) Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 332:635-641
87. Toss H, Lindahl B, Siegbahn A, Wallentin L (1997) Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 96:4204-4210
88. Ulutin T, Sömmez H, Ücisik N, Süer S, Bayram C, Kökoglu E, Sultuybek G (1997) The molecular markers of hemostatic activation on coronary artery disease. Thromb Res 88:329-332
89. van der Wal AC, Becker AE, van der Loos CM, Das PK (1994) Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:36-44
90. van der Wal AC, Becker AE, Koch KT, Pick JJ, Teeling P, van der Loos CM, David GK (1996) Clinically stable angina pectoris is not necessarily associated with histologically stable atherosclerotic plaques. Heart 76:312-316
91. Vaziri ND, Kennedy SC, Kennedy D, Gonzales E (1993) Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris. Am J Med 93:651-657
92. Wiman B, Hamsten A (1990) Correlations between fibrinolytic function and acute myocardial infarction. Am J Cardiol 66:54G-56G
93. Woodhouse PR, Khaw KT, Plummer M, Foley A, Meade TW (1994) Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet 343:435-439
94. Woodward M, Lowe GDO, Rumley A, Tunstall-Pedoe H (1998) Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. Eur Heart J 19:55-62
95. Yasuda M, Takeuchi K, Hiruma M, Iida H, Tahara A, Itagane H, Toda I, Akioka K, Teragaki M, Oku H, Kanayama Y, Takeda T, Kolb WP, Tamerius JD (1990) The complement system in ischemic heart disease. Circulation 81:156-163
96. Zalewski A, Shi Y, Nardone N, Bravette B, Weinstock P, Fischmann D, Wilson P, Goldberg S, Levin DC, Bjornsson TD (1991) Evidence for reduced fibrinolytic activity in unstable angina at rest. Circulation 83:1685-1691